Smart · Journal of molecular and cellular cardiology 2017 · Animal knockout and in vitro laboratory experiment · n=?

Aberrant developmental titin splicing and dysregulated sarcomere length in Thymosin β4 knockout mice.

Cited 11 times in the scientific literature.

Level 5 - mechanism / opinion, no new human data

Animal knockout and in vitro bench study without human data

PubMed 27914791 · doi:10.1016/j.yjmcc.2016.10.010 · record verified 2026-08-29

What was done

The authors investigated the role of Thymosin β4 (Tβ4) in cardiac morphogenesis and adult heart function using Tβ4-null mice and an in vitro cardiomyocyte model. They measured thin filament, sarcomere, and titin spring lengths via immunofluorescence, assessed postnatal titin isoform splicing transitions, and evaluated adult cardiac performance (stroke volume and contractile reserve) using magnetic resonance imaging. They also tested whether adding synthetic Tβ4 in vitro could rescue splicing defects and restore sarcomere length.

What was found

Tβ4-null mice exhibited shortened thin filament, sarcomere, and titin spring lengths in cardiomyocytes, alongside premature upregulation of short titin isoforms during postnatal development. Adult null mice showed reduced stroke volume and limited contractile reserve on MRI (no exact numerical values were reported in the abstract). In vitro, synthetic Tβ4 administration corrected the altered splicing and restored sarcomere length. Similar structural effects were observed in skeletal muscle.

Why it matters

This study reveals a previously unrecognized role of Tβ4 in regulating titin splicing and sarcomere assembly during development. It identifies a potential mechanistic pathway for modulating titin isoforms to address congenital and adult cardiomyopathies.

Limits

The study relies entirely on murine and in vitro models, limiting direct clinical translation. No sample sizes, exact measurements, or statistical values are reported in the abstract. Additionally, the design could not definitively determine whether thin filament shortening or abnormal titin splicing is the primary initiating defect.

Cited by